Tag: paradigm-101

November 14, 2016

InspireMD Announces CGuard(TM) Embolic Prevention System Commercialization Approval in Russia

InspireMD today announced that it has received regulatory approval to commercialize the CGuard™ Embolic Prevention System for the treatment of...
November 1, 2016

InspireMD Presents 12 Month Clinical Trial Data for CGuard Embolic Prevention System

InspireMD today announced 12-month follow up data from PARADIGM-101 of the CGuard™ Embolic Prevention System which were presented in two...